Related references
Note: Only part of the references are listed.Angiosarcoma Clinical and Molecular Insights
Guy Lahat et al.
ANNALS OF SURGERY (2010)
Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular abberations
Jaap Verweij et al.
EUROPEAN JOURNAL OF CANCER (2010)
Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face
Wataru Tokuyama et al.
HUMAN PATHOLOGY (2010)
Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
R. Kumar et al.
BRITISH JOURNAL OF CANCER (2009)
Prognostic Significance of the Expression of Vascular Endothelial Growth Factors A, B, C, and D and Their Receptors R1, R2, and R3 in Patients With Nonsmall Cell Lung Cancer
Enrique Carrillo de Santa Pau et al.
CANCER (2009)
KDR Activating Mutations in Human Angiosarcomas Are Sensitive to Specific Kinase Inhibitors
Cristina R. Antonescu et al.
CANCER RESEARCH (2009)
Vascular Endothelial Growth Factor Receptor Expression as a Prognostic Marker for Survival in Colorectal Cancer
Natsuko Tsuda Okita et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
Robert G. Maki et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: New potential therapeutic targets?
Elvira Stacher et al.
LUNG CANCER (2009)
Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
Tadahiko Kubo et al.
CANCER (2008)
Immunohistochemical Expression of Basic Fibroblast Growth Factor and Fibroblast Growth Factor Receptors 1 and 2 in the Pathogenesis of Lung Cancer
Carmen Behrens et al.
CLINICAL CANCER RESEARCH (2008)
High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEM-2, neuropilin-1) are associated with worse outcome in breast cancer
Sriparna Ghosh et al.
HUMAN PATHOLOGY (2008)
Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study
Nicolas Penel et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Targeting sarcomas: therapeutic targets and their rational
Jose Luis Ordonez et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2008)
Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas
Eijun Itakura et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site:: a retrospective study of 161 cases
J. Fayette et al.
ANNALS OF ONCOLOGY (2007)
Primary angiosarcoma of the breast: Observations in Asian Indian women
Tanuja Shet et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
Serum concentrations of vascular endothelial growth factor-D in angiosarcoma patients
Y Amo et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells
A Üren et al.
ONCOGENE (2003)
Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation
AAP Zada et al.
ONCOGENE (2003)
Platelet-derived growth factor-α receptor expression supports the growth of conventional chondrosarcoma and is associated with adverse outcome
I Sulzbacher et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
KIT expression in angiosarcomas and fetal endothelial calls: Lack of mutations of exon 11 and exon 17 of c-kit
M Miettinen et al.
MODERN PATHOLOGY (2000)
Share Paper
